Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women

• Status: Unknown status
• Trial end date: 2014-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate the efficiency and safety of weekly Cisplatin /Liposome paclitaxel concurrent chemoradiothrapy in the treatment of locally advanced cervical cancer in elderly women.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Health Science Center of Xi'an Jiaotong University; Health Science Center of Xi’an Jiaotong University
• Treatments: Albumin-Bound Paclitaxel; Cisplatin; Paclitaxel

Criteria

Inclusion Criteria:

1. Histologically proven squamous carcinoma of cervix

2. FIGO stageⅡB and ⅢB

3. Over 65 years

4. Do not receive other treatment

5. Performance index ECOG grade 0 to 2

6. Normal ECG

7. Normal hematological parameters

8. Normal renal and liver function tests

Exclusion Criteria:

1. Concomitant disease which may adversely affect the outcome

2. Poor nutritional status

3. Medical or psychological condition precluding treatment

4. Previous treatment

5. Concurrent treatment for any cancer